Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 10, 2010 - Issue 9
Submit an article Journal homepage
719
Views
23
CrossRef citations to date
0
Altmetric
Meeting Report

American Society of Clinical Oncology 2010: report of selected studies from the CNS tumors section

Patrick Y Wen Division of Cancer Neurology, Department of Neurology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA and Center for Neuro-Oncology, Dana-Farber/Brigham and Women’s Cancer Center, SW430B, 44 Binney Street, Boston, MA 02115, USA. [email protected]
Pages 1367-1369 | Published online: 10 Jan 2014

References

  • Franz DN, Krueger DA, Care MM et al. Everolimus for subependymal giant-cell astrocytomas (SEGAs) in tuberous sclerosis. J. Clin. Oncol.28(15 Suppl.) (2010) (Abstract 2004).
  • Brandes AA, Franceschi E, Tosoni A et al. Efficacy of tailored treatment for high- and low-risk medulloblastoma in adults: a large prospective Phase II trial.J. Clin. Oncol.28(15 Suppl.) (2010) (Abstract 2003).
  • Wen PY, Prados M, Schiff D et al. Phase II study of XL184 (BMS 907351), an inhibitor of MET, VEGFR2, and RET, in patients (pts) with progressive glioblastoma (GB).J. Clin. Oncol.28(15 Suppl.) (2010) (Abstract 2006).
  • Norden AD, Drappatz J, Wen PY. Anti-angiogenic therapies for high-grade glioma. Nat. Rev. Neurol.6, 610–620 (2009).
  • Cloughesy T, Vredenburgh JJ, Day B et al. Updated safety and survival of patients with relapsed glioblastoma treated with bevacizumab in the BRAIN study. J. Clin. Oncol.28(15 Suppl.), (2010) (Abstract 2008).
  • Gruber ML, Kunnakkat S, Medabalmi P et al. Change in pattern of relapse in newly diagnosed high-grade glioma following bevacizumab therapy. J. Clin. Oncol.28(15 Suppl.) (2010) (Abstract 2020).
  • Chamberlain MC. Radiographic patterns of relapse in glioblastoma. J. Clin. Oncol.28(15 Suppl.) (2010) (Abstract 2021).
  • Keime-Guibert F, Chinot O, Taillandier L et al. Radiotherapy for glioblastoma in the elderly. N. Engl. J. Med.356, 1527–1535 (2007).
  • Roa W, Brasher PM, Bauman G et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J. Clin. Oncol.22, 1583–1588 (2004).
  • Glantz M, Chamberlain M, Liu Q, Litofsky NS, Recht LD. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer97, 2262–2266 (2003).
  • Wick W, Engel C, Combs SE et al. NOA-08 randomized Phase III trial of 1-week-on/1-week-off temozolomide versus involved-field radiotherapy in elderly (older than age 65) patients with newly diagnosed anaplastic astrocytoma or glioblastoma J. Clin. Oncol.28(18 Suppl.) (2010) (Abstract LBA2001).
  • Malmstrom A, Grønberg BH, Stupp R et al. Glioblastoma (GBM) in elderly patients: a randomized Phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). J. Clin. Oncol.28(18 Suppl.) (2010) (Abstract LBA2002).
  • Drappatz J, Brenner AJ, Rosenfeld S et al. ANG1005: results of a Phase I study in patients with recurrent malignant glioma. J. Clin. Oncol.28(15 Suppl.) (2010) (Abstract 2009).
  • Schiff D, Reardon DA, Kesari S et al. Phase II study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma (rGBM). J. Clin. Oncol.28(15 Suppl.) (2010) (Abstract 2011).
  • Stupp R, Kanner A, Engelhard H et al. A prospective, randomized, open-label, Phase III clinical trial of NovoTTF-100A versus best standard of care chemotherapy in patients with recurrent glioblastoma. J. Clin. Oncol.28(18 Suppl.) (2010) (Abstract LBA2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.